CompletedPhase 2

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

NCT03541603

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Stanford Healthcare

Stanford, California, United States

+15 additional locations

Save this trial

Stanford HealthcareStanford, California, United States
Northwestern Memorial HospitalChicago, Illinois, United States
Tufts Medical CenterBoston, Massachusetts, United States
Massachusetts General HospitalBoston, Massachusetts, United States
Brigham and Women's HospitalBoston, Massachusetts, United States
University of Minnesota Medical CenterMinneapolis, Minnesota, United States
Mayo ClinicRochester, Minnesota, United States
University of Nebraska Medical CenterOmaha, Nebraska, United States
North Shore University HospitalManhasset, New York, United States
New York Presbyterian Hospital-Weill Cornell MedicineNew York, New York, United States
Ichan School of Medicine at Mount SinaiNew York, New York, United States
Christ HospitalCincinnati, Ohio, United States
Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania, United States
University of Pittsburgh Presbyterian HospitalPittsburgh, Pennsylvania, United States
Medical University of South CarolinaCharleston, South Carolina, United States
UW Health University HospitalMadison, Wisconsin, United States